Loading clinical trials...
Loading clinical trials...
CTN-0051: Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment
Conditions
Interventions
Extended-Release Naltrexone
Buprenorphine-Naloxone
Locations
8
United States
Tarzana Treatment Centers
Tarzana, California, United States
Gateway Community Services, Inc.
Jacksonville, Florida, United States
Avery Road Treatment Center
Rockville, Maryland, United States
Stanley Street Treatment and Resources
Fall River, Massachusetts, United States
Turquoise Lodge Hospital
Albuquerque, New Mexico, United States
Bellevue Hospital Center
New York, New York, United States
Start Date
January 29, 2014
Primary Completion Date
January 25, 2017
Completion Date
January 31, 2017
Last Updated
August 13, 2020
NCT04587791
NCT05492825
NCT05942313
NCT06651177
NCT06726200
NCT06843213
Lead Sponsor
NYU Langone Health
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions